<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>Insight数据库 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-29T20:10:28+08:00</updated>
  <subtitle>丁香园 Insight 数据库（db.dxy.cn），拥有申报、临床、上市、药企等 10 大核心数据。致力于分享医药行业政策解读、药企大事和药品申报情报等</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>今日超 30 款仿制药过评！6 个第四批国采品种，5 个首家过评注射剂</title>
    <updated>2020-12-29T18:46:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/rNocjUf2Wa8igl7OuLoZOQ</id>
    <link href="https://mp.weixin.qq.com/s/rNocjUf2Wa8igl7OuLoZOQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>和黄医药向 FDA 递交「索凡替尼」新药上市申请</title>
    <updated>2020-12-29T18:46:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/DX_kVpfRXAJC2gVx-80njg</id>
    <link href="https://mp.weixin.qq.com/s/DX_kVpfRXAJC2gVx-80njg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>大咖齐聚新年煮酒论医药！丨BIO APAC 2021，1月20-21日上海</title>
    <updated>2020-12-29T18:46:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/rbemfu-oRhScmKkvnyyqRg</id>
    <link href="https://mp.weixin.qq.com/s/rbemfu-oRhScmKkvnyyqRg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年医保谈判现场曝光！国产新药迎来降价潮（附部分降幅整理）</title>
    <updated>2020-12-28T18:21:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/8cnpUbKQfC9WwlVWXzf-kA</id>
    <link href="https://mp.weixin.qq.com/s/8cnpUbKQfC9WwlVWXzf-kA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 年医保目录官方解读：12 个你最关注的问题！</title>
    <updated>2020-12-28T18:21:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/fl1fezmxdHo8rRjXYEJ94g</id>
    <link href="https://mp.weixin.qq.com/s/fl1fezmxdHo8rRjXYEJ94g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>手握多款首创药，德琪医药是否被资本市场「错杀」？</title>
    <updated>2020-12-25T20:07:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/5x2Z0Rj9cbWq_41DX8sQrw</id>
    <link href="https://mp.weixin.qq.com/s/5x2Z0Rj9cbWq_41DX8sQrw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>礼来「阿贝西利」即将获批，国内第 2 款 CDK4/6 抑制剂</title>
    <updated>2020-12-25T20:07:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/XoXbfltTo4CfNbpTZX8hPw</id>
    <link href="https://mp.weixin.qq.com/s/XoXbfltTo4CfNbpTZX8hPw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今日 8 个仿制药过评，11 个仿制药获批：3 个首家，3 个国采品种</title>
    <updated>2020-12-25T16:44:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/CXWCoKwdZUh3159mS18gjw</id>
    <link href="https://mp.weixin.qq.com/s/CXWCoKwdZUh3159mS18gjw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>60 亿重磅品种！头孢呋辛注射剂迎来首家过评</title>
    <updated>2020-12-25T16:44:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/U-9b7CpvDZZ281Ds-b0Ikw</id>
    <link href="https://mp.weixin.qq.com/s/U-9b7CpvDZZ281Ds-b0Ikw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞 CDK4/6 抑制剂乳腺癌 III 期临床达到终点！拟近期报上市</title>
    <updated>2020-12-25T16:44:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/36cRFD88zTGbeLS3xrOpHQ</id>
    <link href="https://mp.weixin.qq.com/s/36cRFD88zTGbeLS3xrOpHQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国产疫苗新动向！国药集团新冠疫苗上市申请获承办</title>
    <updated>2020-12-24T12:03:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/94gp-AMnrOtnmGBMV7TQ-w</id>
    <link href="https://mp.weixin.qq.com/s/94gp-AMnrOtnmGBMV7TQ-w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞「氟唑帕利」新适应症报上市！复发性卵巢癌维持治疗</title>
    <updated>2020-12-24T12:03:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/Hy_-0DwDZjhNfsQXuHmbPg</id>
    <link href="https://mp.weixin.qq.com/s/Hy_-0DwDZjhNfsQXuHmbPg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞「阿帕替尼」肝癌新适应症即将获批！CSCO 指南 I 级推荐</title>
    <updated>2020-12-23T16:04:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/hez8VeNeAzQ0qi4lfb1PFA</id>
    <link href="https://mp.weixin.qq.com/s/hez8VeNeAzQ0qi4lfb1PFA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首家解读！2020 国家医保药品目录调整看点多多！</title>
    <updated>2020-12-23T16:04:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/ozY8juUMfYnjia6SnXCWFA</id>
    <link href="https://mp.weixin.qq.com/s/ozY8juUMfYnjia6SnXCWFA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今日 7 款仿制药通过一致性评价，第四批国采重磅品种已有 8 家竞争！</title>
    <updated>2020-12-23T16:04:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/5Zs6KJzdq4eePRXlF3-_CA</id>
    <link href="https://mp.weixin.qq.com/s/5Zs6KJzdq4eePRXlF3-_CA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信达生物「阿达木单抗」获批两项新适应症</title>
    <updated>2020-12-23T16:04:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/IA1t4x6PzLIae4b9C6dU1A</id>
    <link href="https://mp.weixin.qq.com/s/IA1t4x6PzLIae4b9C6dU1A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>正大天晴「安罗替尼」第 4 个适应症即将获批，用于甲状腺髓样癌</title>
    <updated>2020-12-23T16:04:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/nLJEvK9Ohb5OBESvCYGO4g</id>
    <link href="https://mp.weixin.qq.com/s/nLJEvK9Ohb5OBESvCYGO4g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PK 勃林格殷格翰，首款国产尼达尼布即将出线</title>
    <updated>2020-12-23T16:04:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/eRGEmJ4wf8Vw_Dv5Li4nEQ</id>
    <link href="https://mp.weixin.qq.com/s/eRGEmJ4wf8Vw_Dv5Li4nEQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>贝达药业第四代 EGFR 抑制剂临床申请获受理</title>
    <updated>2020-12-23T16:04:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/be7lBnYthy83rR95_gjqnQ</id>
    <link href="https://mp.weixin.qq.com/s/be7lBnYthy83rR95_gjqnQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>30 亿大品种迎来首家过评！北京泰德&amp;南京健友「苯磺顺阿曲库铵注射液」获批上市</title>
    <updated>2020-12-23T16:04:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/yKI9RBeb9dv47pQuokGdlQ</id>
    <link href="https://mp.weixin.qq.com/s/yKI9RBeb9dv47pQuokGdlQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>